OnEquity Earns “Best Multi-Asset Institutional Broker – APAC” at UF AWARDS 2025 Award highlights OnEquity's commitment to institutional excellence, transparency, and innovation GlobeNewswire November 04, 2025 HONG KONG, Nov. 04, 2025 (GLOBE NEWSWIRE) — OnEquity, a globally regulated multi-asset brokerage, has been awarded the title of “Best Multi-Asset Institutional Broker – APAC” at the UF […]
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Marex Group Plc ("Marex" or the "Company") (NASDAQ:MRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation ("Fluor" or the "Company") (NYSE:FLR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE:NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or "the Company") (NYSE:BAX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / November 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sina Corporation ("Sina" or "the Company") (NASDAQ:SINA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Savara Inc. ("Savara" or "the Company") (NASDAQ:SVRA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients Platinum sponsorship of NF Caregivers Symposium reinforces commitment to NF1 community GlobeNewswire November 04, 2025 MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the